Indications:
- Type 2 Diabetes Mellitus (T2DM):
As an adjunct to diet and exercise to improve glycemic control in adults with T2DM. - Chronic Weight Management (Obesity or Overweight):
In adults with a body mass index (BMI) ≥30 kg/m² (obesity) or ≥27 kg/m² (overweight) with at least one weight-related comorbidity (e.g., hypertension, dyslipidemia, or T2DM), as an adjunct to reduced-calorie diet and increased physical activity.
Important Off-label or Investigational Uses:
- Non-alcoholic Steatohepatitis (NASH):
Being studied for potential benefit in improving liver histology in patients with NASH. - Cardiovascular Risk Reduction:
Investigated for reducing major adverse cardiovascular events (MACE) in patients with type 2 diabetes and established cardiovascular disease or risk factors.
Reviews
There are no reviews yet.